On September 13, 2023 we hosted Dr. Jason Hao for a FREE webinar, Chinese Scalp Acupuncture for Difficult Neurological Disorders and Long COVID Symptoms.

Scalp acupuncture has been used as a modern acupuncture technique for more than 50 years. Scalp acupuncture is an integrative medicine treatment that combines traditional acupuncture with modern neuroscience. Research shows that scalp acupuncture has significant efficacy in the treatment of central nervous system diseases, including cerebral palsy, stroke, multiple sclerosis, stroke, Parkinson’s Disease, brain injury, autism, phantom limb pain, complex regional pain, and long COVID symptoms.

Half a century of acupuncture practice has shown that all functions of the human brain have corresponding projection areas on the scalp, and by stimulating different projection areas of the scalp, they have a direct impact on the cerebral cortex, cerebellum, thalamus, hypothalamus and pineal gland, thereby improving their corresponding functional defects. Modern studies have shown that scalp acupuncture can significantly increase cerebral blood flow, improve brain cell metabolism, promote partial or complete compensation of brain function, and have a certain role in promoting the repair and functional plasticity of brain tissue.

Scalp acupuncture has shown its unique advantages in the treatment of post-COVID symptoms and other central nervous system diseases. Scalp acupuncture can not only improve the limb dysfunction caused by its neurological function defects, but also show great advantages in improving cognitive function, improving communication ability, and adjusting bad emotions, and greatly improving patients’ recovery ability. The treatment of difficult neurological diseases and long COVID symptoms has brought good news to the recovery of patients, enhanced the confidence of TCM acupuncturists, and laid a good foundation for domestic and foreign scientific research institutions and colleges to further study the clinical application and mechanism of head acupuncture.

Join Dr. Jason Hao as he discusses Chinese scalp acupuncture for difficult neurological disorders and long COVID symptoms.

What you will learn:

• Understand the history, theory, and research of Chinese scalp acupuncture
• Master the locations, proper needling, and clinical applications of some scalp acupuncture areas
• Design and execute special treatments for the disorders accessible to this discipline
• Improve their effective recovery rate for neurological disorders
• Help patients with even the most challenging and difficult conditions
• Add a new high-level skill and performance to their clinical acupuncture practice

About Our Speakers:

Jason Jishun Hao is editor-in-chief and translator-in-chief for the textbook ACUPUNCTURE AND MOXIBUSTION published by World Federacy of Chinese Medicine Society. Jason Hao currently serves as the vice-chairman for the education guiding committee and vice-chairman for the translation committee at World Federacy of Chinese Medicine Society. Jason Hao is the president of the Neuro-acupuncture Institute in the USA. He was the former chairman of the acupuncture committee in the National Certification Commission of Acupuncture and Oriental Medicine (NCCAOM). He is the co-author of the book, Chinese Scalp Acupuncture.

Jason Hao has been practicing and researching scalp acupuncture for thirty-nine years and has been teaching classes and seminars in the USA and Europe since 1989. Hao gave a scalp acupuncture seminar at Walter Reed Medical Center in Washington DC where he successfully demonstrated scalp acupuncture treatment of CRPS and phantom pain for veterans. Jason Hao specializes in treating neurological disorders, such as stroke, multiple sclerosis, traumatic brain injury, PTSD, cerebral palsy, autism, complex regional pain, and phantoms. Many American newspapers, journals, and television shows have reported his successful cases and stories in the past 30 years. The documentary film by Doug Dearth on him and his wife, Linda Hao’s treatments, “RETURN TO LIFE” was released on May, 2021.